Details for Patent: 6,814,978

Which drugs does patent 6,814,978 protect, and when does it expire?

Patent 6,814,978 protects PEPCID AC and PEPCID COMPLETE and is included in two NDAs.

Protection for PEPCID AC has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,814,978

Title:	Process for preparing a soft tablet
Abstract:	The invention relates to a process for preparing a soft tablet capable of being chewed or disintegrated in the oral cavity. The tablet is prepared by forming a tablet having a friability of less than about 2% from a mixture comprising a pharmaceutically active ingredient, an excipient in the form of a hydrate, and a water-swellable excipient, and then applying sufficient energy, preferably in the form of heat, to the tablet for a sufficient time to decrease the hardness of the tablet by at least about 20%.
Inventor(s):	Bunick; Frank J. (Randolph, NJ), Luber; Joseph (Quakertown, PA)
Assignee:	McNeil-PPC, Inc. (Skillman, NJ)
Application Number:	09/752,601
Patent Claim Types: see list of patent claims	Compound; Dosage form; Composition; Process;

Drugs Protected by US Patent 6,814,978

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
J And J Consumer Inc	PEPCID AC	famotidine	TABLET, CHEWABLE;ORAL	020801-002	Dec 17, 2007		OTC	Yes	Yes
J And J Consumer Inc	PEPCID COMPLETE	calcium carbonate; famotidine; magnesium hydroxide	TABLET, CHEWABLE;ORAL	020958-001	Oct 16, 2000		OTC	Yes	Yes